McKinsey, the FDA, and the Medical-Industrial Complex.
Mike Magee In today’s New York Times, Dr. Joshua M. Sharfstein, professor at the Bloomberg School of Public Health at Johns Hopkins, and principal deputy commissioner of the Food and Drug Administration from 2009 to 2011, recounted global consulting firm McKinsey’s simultaneous working relations with the FDA and Purdue Pharma. The Congressional investigation currently underway […]